Home US News Remdesivir cures 50% of COVID-19 Patients in Indian-American Clinical Trial

Remdesivir cures 50% of COVID-19 Patients in Indian-American Clinical Trial

According to the US Pharma company, Remdesivir is showing positive results in the clinical trials. The antiviral drug is under phase three clinical trials, which are being monitored by a team on investigators.

The team of investigators also include an Indo-American Physician who is overseeing the clinical trials in the US.

As per the reports (US News) given by Gilead Sciences company, two different sets of tests took place where one group of patients received a 5-day dosage, and another group of patients received a 10-day dosage.

Both types of analysis yielded almost similar results as there was no significant difference in results due to the fluctuation of dosages. However, comprehensive data is yet to come, and once it is prepared, the conclusion will be made.

Fifty percent of the COVID-19 patients got treated with Remdesivir antiviral drugs during the clinical trials. Data also shows that more than 50 percent of people were sent home from the hospitals’ under two weeks.

Investigators believe that they are on the verge of drug approval, and in no time, it will be available World-wide.

Currently, Remdesivir has not been approved by any global institution, and it is not recommended to be used. Until now, Remdesivir is not scientifically proved that it is safe or not for the human body.

Remdesivir also works like other drugs, which create several copies of the virus in the human body and acts as a protective shield in the human body.

Rashi Gupta - professional Digital Marketing consultant with Google certification, Passionate about reading and writing latest facts on Science and Technology and now a full-time contributor to Journal Headlines. Rashi is the base behind the Science coverage over this online news platform.


Please enter your comment!
Please enter your name here

Most Popular

After Trump Fact Check: Twitter indicates China official posts on Covid-19

Twitter fact-checks China official post claiming coronavirus originated in the U.S. Twitter, listed below severe analysis for its...

No One Wants to Hear From the Birther-in-Chief on George Floyd

CNN support Don Lemon said on Donald Trump just after the Justice branch described Thursday that head of state became "proactively...

NASA’s SpaceX Launch Mission Delayed Until Saturday: Why

NASA and Space X Mission Delayed Until Saturday At the point when you have a 230-ft, Tall rocket loaded...

Twitter Restricts Trump’s Tweet For Violating Policy of “Glorification of Violence”- US News

Trump has been found guilty by Twitter for Violating Twitter’s policies of hateful content. Therefore, according to the policies Tweets of Donald...